University of Florida
Gainesville, Florida, 32610, United States
NCT Number: NCT00601068
In cooperation with Merck & Co, Inc. we will identify and form a database of 35 patients who have developed osteochemonecrosis of the jaws related to oral bisphosphonate use. We will study the triggers, associated medical conditions and medications, location of the lesion(s), and patient outcomes.
Looking for future studies?
Notify Me30 year–90 year
All sexes
Observational
Gainesville, Florida, 32610, United States
This study is an observational study, and not a comparative trial. The major outcome is represented by the fraction of subjects with long term healed lesions.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Group of patients with osteochemonecrosis related to oral bisphosphonate use
Other names: Osteochemonecrosis
Time frame: 2 years
University of Florida
Other
Proposal For The Development Of A Well Defined Database For Patients With Oral Bisphosphonate-Related Osteonecrosis of the Jaws (BON)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04401267
Bone Diseases, Cardiovascular Diseases
Charlotte, North Carolina, United States
View Trial DetailsNCT02893293
Bone Diseases, Musculoskeletal Diseases
Stanford, California, United States
View Trial DetailsNCT05684588
Bone Diseases, COVID-19
Bergamo, Lombardy, Italy
View Trial DetailsNCT01892514
Bone Diseases, Musculoskeletal Diseases
Bologna, Italy
View Trial Details